Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,035
Closed -$946K 207
2025
Q1
$946K Sell
3,035
-30
-1% -$8.86K 0.36% 80
2024
Q4
$824K Buy
3,065
+147
+5% +$43.6K 0.32% 86
2024
Q3
$940K Sell
2,918
-526
-15% -$172K 0.37% 77
2024
Q2
$1.08M Buy
3,444
+158
+5% +$46.4K 0.34% 80
2024
Q1
$934K Buy
3,286
+361
+12% +$106K 0.31% 91
2023
Q4
$887K Buy
2,925
+510
+21% +$139K 0.32% 95
2023
Q3
$678K Buy
+2,415
New +$603K 0.28% 111

Other funds holding AMGN

My Legacy Advisors's AMGN Position: Q2 2025 in Review

My Legacy Advisors sold out of Amgen (AMGN) in Q2 2025, closing a stake of 3,035 shares — an estimated $946K sold.

My Legacy Advisors first reported a position in AMGN in Q3 2023 and held it in 7 quarters. The position peaked at $1.08M in Q2 2024. 2,851 funds tracked by Wall St. Rank hold AMGN as of Q2 2025.

  • My Legacy Advisors reported no remaining Amgen position as of Q2 2025 after selling out during the quarter.
  • My Legacy Advisors sold 3,035 Amgen shares in Q2 2025, an estimated $946K.
  • My Legacy Advisors first reported a position in Amgen in Q3 2023 and held it in 7 quarters.
  • My Legacy Advisors's Amgen position peaked at $1.08M in Q2 2024.
  • 2,851 funds tracked by Wall St. Rank held Amgen as of Q2 2025.

Based on My Legacy Advisors's 13F filing for Q2 2025, filed 11 Jul 2025.